Aoife Brennan, the President and CEO of $CLYM, sold 30,902 shares of the company on 06-29-2026 for an estimated $406,979. We received data on the trade from a recent SEC filing. This was a sale of approximately 26.0% of their shares of this class of stock. Following this trade, they now own 87,731 shares of this class of $CLYM stock.
$CLYM Insider Trading Activity
$CLYM insiders have traded $CLYM stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CLYM stock by insiders over the last 6 months:
- STEPHEN BASIL THOMAS has made 0 purchases and 4 sales selling 150,000 shares for an estimated $879,381.
- AOIFE BRENNAN (President and CEO) sold 30,902 shares for an estimated $406,979
- CAPITAL MANAGEMENT, L.P. RA purchased 7,111 shares for an estimated $24,888
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CLYM Hedge Fund Activity
We have seen 47 institutional investors add shares of $CLYM stock to their portfolio, and 47 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TANG CAPITAL MANAGEMENT LLC removed 1,000,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $4,000,000
- MILLENNIUM MANAGEMENT LLC added 979,946 shares (+330.7%) to their portfolio in Q1 2026, for an estimated $6,712,630
- GREAT POINT PARTNERS LLC added 979,534 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,918,136
- ADAR1 CAPITAL MANAGEMENT, LLC removed 834,813 shares (-58.3%) from their portfolio in Q1 2026, for an estimated $5,718,469
- SILVERARC CAPITAL MANAGEMENT, LLC added 684,908 shares (+inf%) to their portfolio in Q1 2026, for an estimated $4,691,619
- POINT72 ASSET MANAGEMENT, L.P. removed 657,590 shares (-91.8%) from their portfolio in Q1 2026, for an estimated $4,504,491
- AFFINITY ASSET ADVISORS, LLC removed 600,000 shares (-46.2%) from their portfolio in Q1 2026, for an estimated $4,110,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CLYM Analyst Ratings
Wall Street analysts have issued reports on $CLYM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/13/2026
To track analyst ratings and price targets for $CLYM, check out Quiver Quantitative's $CLYM forecast page.
$CLYM Price Targets
Multiple analysts have issued price targets for $CLYM recently. We have seen 12 analysts offer price targets for $CLYM in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $20.0 on 06/24/2026
- Laura Chico from Wedbush set a target price of $17.0 on 06/12/2026
- Julian Harrison from BTIG set a target price of $20.0 on 06/11/2026
- Yatin Suneja from Guggenheim set a target price of $35.0 on 06/08/2026
- Geulah Livshits from Chardan Capital set a target price of $22.0 on 05/05/2026
- Leland Gershell from Oppenheimer set a target price of $18.0 on 04/21/2026
- Joseph Catanzaro from Mizuho set a target price of $18.0 on 04/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
